The Janus kinase inhibitor baricitinib, in combination with narrowband ultraviolet B therapy, improved vitiligo, according to a study.“The use of phototherapy alongside [Janus kinase (JAK)] inhibitors ...
Combining baricitinib with narrowband UVB phototherapy led to significant repigmentation and enhanced quality of life in ...
In a phase 2 clinical trial, researchers examined baricitinib and NB-UVB in adults with severe vitiligo in the dermatology ...
If you’re under age 12, we don’t have any drug that is specifically indicated,” Dr. Lawrence F. Eichenfield said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results